<p>* Data or sample not available from one or both volunteers</p><p>** Transmitting partner reports use of antiretroviral therapy, EDI: Estimated date of infection in the incident case</p><p>°An additional 6 volunteers reported being on ART at or around the time of the transmission event, however their viral load was too low to sequence for linkage analysis</p><p><sup>▪</sup> Comparing linked vs. unlinked across volunteer characteristic</p><p><sup>▪▪</sup> Divorced, separated or widowed</p><p>Demographic characteristics of the suspected transmitting partners of incident cases reported to be in HIV discordant couple relationships.</p
<p>Behavioral characteristics reported at enrollment for 586 discordant couples with participants cl...
†<p>Based on 57 couples where positive partner had at least one CD4 count result.</p>††<p>Based on 5...
Early initiation of antiretroviral therapy reduces risk of transmission to the uninfected partner in...
<p>Demographic and clinical characteristics reported at enrollment for 586 discordant couples with p...
BackgroundHIV-1-discordant couples that remain discordant despite repeated exposure may differ from ...
BackgroundHIV-1-discordant couples that remain discordant despite repeated exposure may differ from ...
Public health interviews (i.e., partner services), during which persons with diagnosed human immunod...
In the HPTN 052 study, transmission between HIV-discordant couples was reduced by 96 % when the HIV-...
The Partners HSV-2/HIV-1 Transmission Study (Partners Study) is a phase III, placebo-controlled tria...
<p>LDL: lower detection limit, which for this study was 50 copies/ml.</p>*<p>All 5 seroconverters an...
Statistical analyses of data form studies of Human Immunodeficiency Virus (HIV) transmission in part...
Demographic characteristics of the study population stratified by index cases, HIV uninfected partne...
1<p>Analyses weighted with standard DHS sampling weights for study design and non-response.</p>2<p>I...
BackgroundThe Partners HSV-2/HIV-1 Transmission Study (Partners Study) is a phase III, placebo-contr...
Characteristics of sexual partnerships, as well as those of the individuals involved, might influenc...
<p>Behavioral characteristics reported at enrollment for 586 discordant couples with participants cl...
†<p>Based on 57 couples where positive partner had at least one CD4 count result.</p>††<p>Based on 5...
Early initiation of antiretroviral therapy reduces risk of transmission to the uninfected partner in...
<p>Demographic and clinical characteristics reported at enrollment for 586 discordant couples with p...
BackgroundHIV-1-discordant couples that remain discordant despite repeated exposure may differ from ...
BackgroundHIV-1-discordant couples that remain discordant despite repeated exposure may differ from ...
Public health interviews (i.e., partner services), during which persons with diagnosed human immunod...
In the HPTN 052 study, transmission between HIV-discordant couples was reduced by 96 % when the HIV-...
The Partners HSV-2/HIV-1 Transmission Study (Partners Study) is a phase III, placebo-controlled tria...
<p>LDL: lower detection limit, which for this study was 50 copies/ml.</p>*<p>All 5 seroconverters an...
Statistical analyses of data form studies of Human Immunodeficiency Virus (HIV) transmission in part...
Demographic characteristics of the study population stratified by index cases, HIV uninfected partne...
1<p>Analyses weighted with standard DHS sampling weights for study design and non-response.</p>2<p>I...
BackgroundThe Partners HSV-2/HIV-1 Transmission Study (Partners Study) is a phase III, placebo-contr...
Characteristics of sexual partnerships, as well as those of the individuals involved, might influenc...
<p>Behavioral characteristics reported at enrollment for 586 discordant couples with participants cl...
†<p>Based on 57 couples where positive partner had at least one CD4 count result.</p>††<p>Based on 5...
Early initiation of antiretroviral therapy reduces risk of transmission to the uninfected partner in...